This article, which appears in the Fall 2005 edition of Bio-Science Law Review, relates to the current position in the United States on the patentability of stem cell related intellectual property, the regulation of human embryo cell line research at both the state and federal level, and the relationship, if any, between patentability and regulation.
9/1/2005 | Bio-Science Law Review
Stem Cells and Patenting and Related Regulatory Issues: A United States Perspective
1 min
Related Services
Related Insights
David Barr Co-Authors the 2024 Edition of the PLI Treatise
David Barr Co-Authors the 2024 Edition of the PLI Treatise
July 24, 2024
1min
FDA Approves Second Soliris® (eculizumab) Interchangeable Biosimilar – Samsung Bioepis’s Epysqli® (eculizumab-aagh)
FDA Approves Second Soliris® (eculizumab) Interchangeable Biosimilar – Samsung Bioepis’s Epysqli® (eculizumab-aagh)
July 24, 2024
2min
Understanding the Work Made for Hire Doctrine in Copyright Law – Part 2
Understanding the Work Made for Hire Doctrine in Copyright Law – Part 2
July 16, 2024
3min
Recent News
In Conversation: Nearly Two Years On, Paul Battista and Michael Joblove Assess the Impact of Venable’s Expansion into Florida
In Conversation: Nearly Two Years On, Paul Battista and Michael Joblove Assess the Impact of Venable’s Expansion into Florida
July 24, 2024
5min
Noise in the Basement to Take Stage at Law Rocks DC
Noise in the Basement to Take Stage at Law Rocks DC
July 23, 2024
2min
Sean Franzblau Joins Venable’s Investigations and White Collar Defense Practice in Chicago
Sean Franzblau Joins Venable’s Investigations and White Collar Defense Practice in Chicago
July 23, 2024
2min